The Anti-Gangliosid Dot is a qualitative line immunoassay for the determination of IgG or IgM antibodies against gangliosides in human serum. The Anti-Gangliosid Dot is intended as an aid in the diagnosis of peripheral neurological disorders in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.
5003 – Anti-Gangliosid Dot
Autoimmunity, Diagnostics, LINE / Dot
5003 – Anti-Gangliosid Dot
Line immunoassay for the qualitative determination of IgG and / or IgM antibodies against gangliosides in human serum
Available Downloads:
| Indication | Autoimmune neuropathies |
|---|---|
| Format | Test strips coated with GM1, GM2, GM3, GM4, GD1a, GD1b, GD2, GD3, GT1a, GT1b, GQ1b and sulfatides |
| Total incubation time | 190 min |
| Sample volume | 10 µL serum |
| No. of determinations | 24 x 12 |
Related products
-
3850 – Anti-GP2 IgG
Enzyme immunoassay for the quantitative determination of IgG antibodies against glycoprotein 2 in human serum
-
8065 – CytoBead® ANA
Indirect immunofluorescence assay for the determination of IgG antibodies in human serum against nuclear and cytoplasmic antigens
-
3506 – Medizym® anti-IA2 M
Enzyme immunoassay for the quantitative determination of antibodies against Protein Tyrosine Phosphatase (IA2) in human serum